NCT00332345View on ClinicalTrials.gov

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

August 31, 1999

Study Completion Date

August 31, 1999

Conditions
Ocular Hypertension
Interventions
DRUG

brimonidine/timolol fixed combination

Trial Locations (1)

Unknown

Artesia

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY